9 completed, 4 unknown, 2 terminated, 1 active not recruiting. 17 Phase 2, 8 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 17 | Completed 9, Unknown 4, Terminated 2, Active not recruiting 1, Withdrawn 1 |
| Phase 1 | 8 | Completed 3, Terminated 2, Unknown 2, Withdrawn 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Diabetic Foot Ulcers: new trials by email Literature Review of Diabetic Foot Ulcers trials Research Report on Diabetic Foot Ulcers
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers Antimicrobial Peptide PL-5 Topical Spray and Placebo - Diabetic Foot Ulcers | Phase 2 | Active not recruiting | Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. | 90 | 2024-01-30 | 2025-05-25 |
| The Effect of Platelet-Rich Plasma-Fibrin Glue in Combination With Vitamin E and C for Treatment of Non-healing Diabetic Foot Ulcers PRP-Fibrin Glue, Vitamin E and C, Placebo - Diabetic Foot Ulcers, Diabetic Wound | Phase 2 / Phase 3 | Unknown | Mashhad University of Medical Sciences | 24 | 2019-08-28 | 2020-03-20 |
| Wound Healing Endpoint and Recurrence Epiceram Skin Barrier Function, Vaseline Petroleum Jelly - Chronic Wound, Burn Wound | Phase 1 / Phase 2 | Completed | Sashwati Roy | 106 | 2019-01-08 | 2026-11-18 |
| Evaluation of ABSOLVE in Diabetic Foot Ulcers RhPDGF-BB, Placebo - Diabetic Foot Ulcers | Phase 2 | Unknown | Lynch Biologics LLC | 40 | 2017-01-30 | 2017-01-31 |
| Safety and Exploratory Efficacy Study of Collagen Membrane With Mesenchymal Stem Cells in the Treatment of Skin Defects Medical Collagen Membrane with MSC, Medical Collagen Membrane - Wounds, Diabetic Foot Ulcers | Phase 1 / Phase 2 | Unknown | South China Research Center for Stem Cell and Regenerative Medicine | 30 | 2016-05-01 | 2016-02-03 |
| Safety and Efficacy of Low Intensity Shockwave Therapy in Treating Diabetic Foot Ulcers Extracorporeal Shockwave Therapy and debridement, debridement and cleaning - Diabetic Foot Ulcers | Phase 1 / Phase 2 | Unknown | Hadassah Medical Organization | 30 | 2016-04-01 | 2016-02-25 |
| Study of Safety, Tolerability, and Pharmacokinetics of Topical Selinexor (KPT-330) Diabetic Foot Ulcer (DFU) Patients Selinexor, Standard-of-Care, Vehicle Gel - Diabetic Foot Ulcers | Phase 1 / Phase 2 | Withdrawn | Karyopharm Therapeutics Inc | 2015-01-01 | 2023-01-20 | |
| Safety and Efficacy of Gentamicin Topical Gel (AppliGel-G) for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers Gentamicin Topical Gel, Ciprofloxacin, Doxycycline - Diabetic Foot Ulcers | Phase 1 / Phase 2 | Terminated | Royer Biomedical, Inc. | 9 | 2014-01-01 | 2015-05-14 |
| A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers MEBO Wound Ointment (MEBO), Standard of Care - Diabetic Foot Ulcers | Phase 2 | Completed | Skingenix, Inc. | 75 | 2012-09-01 | 2025-11-06 |
| A Study to Investigate the Safety and Clinical Effect of Nexagon® as a Topical Treatment for Subjects With a Diabetic Foot Ulcer (DUNE) Nexagon® Low Dose, Nexagon® Medium Dose, Nexagon® High Dose - Diabetic Foot Ulcers | Phase 2 | Completed | OcuNexus Therapeutics, Inc. | 168 | 2012-07-01 | 2014-05-01 |
| Utilization of Platelet Gel for Treatment of Diabetic Foot Ulcers Platelet Gel, Placebo - Diabetic Foot Ulcers | Phase 1 / Phase 2 | Completed | Royan Institute | 30 | 2012-01-01 | 2015-12-04 |
| A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot) MEBO Wound Ointment, Standard of Care (sterile saline moistened gauze) - Diabetic Foot Ulcers | Phase 2 | Completed | Skingenix, Inc. | 7 | 2010-11-01 | 2025-11-06 |
| Comparative Study of 3 Dose Regimens of BioChaperone to Becaplermin Gel for the Treatment of Diabetic Foot Ulcer Biochaperone PDGF-BB Low dose, Biochaperone PDGF-BB High dose, Regranex - Diabetic Foot Ulcers | Phase 1 / Phase 2 | Completed | Virchow Group | 192 | 2010-06-01 | 2014-12-15 |
| Transdermal Continuous Oxygen Therapy for Diabetic Foot Ulcers Epiflo, Moist Wound Therapy - Diabetic Foot Ulcers | Phase 2 / Phase 3 | Completed | Neogenix, LLC dba Ogenix | 130 | 2009-10-01 | 2014-05-13 |
| Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers ATG002 (study drug) - Diabetic Foot Ulcers | Phase 1 / Phase 2 | Terminated | CoMentis | 48 | 2006-10-01 | 2007-08-09 |
| Clinical Trials of Footwear in Patients With Diabetes-Study Arm 2,3 Prevention of Diabetic Ulcers - Diabetic Foot Ulcers | Phase 2 | Completed | US Department of Veterans Affairs | 427 | 2000-10-01 | 2009-01-21 |
| Investigation of Subatmospheric Pressure Dressing on Pressure Ulcer Healing Prevention of Pressure Ulcers - Diabetic Foot Ulcers | Phase 2 | Completed | US Department of Veterans Affairs | 120 | 2000-01-01 | 2009-02-09 |
Diabetic Foot (17) · Foot Ulcer (5) · Diabetes Mellitus (3) · Wounds and Injuries (3) · Burns (2) · Pressure Ulcer (2) · Bronchiolitis Obliterans Syndrome (1) · Infections (1) · Ulcer (1) · Wound Infection (1)
Cardiovascular Diseases (17) · Diabetes Complications (17) · Diabetic Angiopathies (17) · Diabetic Neuropathies (17) · Endocrine System Diseases (17) · Leg Ulcer (17) · Skin Diseases (17) · Skin Ulcer (17) · Skin and Connective Tissue Diseases (17) · Vascular Diseases (17) · Diabetes Mellitus (14) · Foot Ulcer (12) · Foot Diseases (5) · Glucose Metabolism Disorders (3) · Metabolic Diseases (3)
Standard of Care (3) · Becaplermin (2) · Ciprofloxacin (1) · Debridement (1) · Doxycycline (1) · Drug Evaluation (1) · Extracorporeal Shockwave Therapy (1) · Petroleum (1) · Vitamin E (1) · selinexor (1)
Skingenix, Inc. (2) · US Department of Veterans Affairs (2) · CoMentis (1) · Hadassah Medical Organization (1) · Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. (1) · Karyopharm Therapeutics Inc (1) · Lynch Biologics LLC (1) · Mashhad University of Medical Sciences (1) · Neogenix, LLC dba Ogenix (1) · OcuNexus Therapeutics, Inc. (1) · Royan Institute (1) · Royer Biomedical, Inc. (1) · Sashwati Roy (1) · South China Research Center for Stem Cell and Regenerative Medicine (1) · Virchow Group (1)
United States (10) · Iran (2) · Guatemala (1) · India (1) · New Zealand (1) · Russia (1) · Ukraine (1)
Robert S Kirsner, MD, PhD (2) · Alireza Goodarzi, MSc (1) · Behnam Molavi, MD (1) · Daryoush Hamidi Alamdari, Ph.D (1) · David G Armstrong, DPM MD PhD (1) · Hamid Gourabi, PhD (1) · Henry Hsu, MD (1) · John Fryer, Ph.D. Asst. Director (1) · Luis Gonzalez, MD (1) · Michael Longaker, MD (1) · Nasser Aghdami, MD,PhD (1) · Sashwati Roy, PhD (1) · Seyedeh Esmat Hosseini, Bs (1) · T C Raghuram, MD, Phd (1) · Vickie R Driver, MSDPM FACFAS (1)